Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Novartis (Germany) | Researchclopedia

Back to institutions

Novartis (Germany)

Nurembergcompany

1,769

Works

146,929

Citations

187

h-index

Top Research Topics

Influenza Virus Research Studies Advanced Breast Cancer Therapies Renal Transplantation Outcomes and Treatments

Top Researchers

Matthew Meyerson Broad Institute

1,857 works307,627 citationsh-index: 223

Recent Research

Real‐world progression‐free survival and overall survival in patients with <scp>HR</scp> <sup>+</sup> / <scp>HER2</scp> <sup>−</sup> advanced breast cancer treated in first‐line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational <scp>RIBANNA</scp> study

P. Fasching,Cosima Veronika Maria Brucker,et al.

20260 citations

Chronic Myeloid Leukemia Treatments

Psoriasis: Treatment and Pathogenesis

Dermatology and Skin Diseases

Asthma and respiratory diseases

Multiple Sclerosis Research Studies

Spondyloarthritis Studies and Treatments

Retinal Diseases and Treatments

Blood Pressure and Hypertension Studies

Health Systems, Economic Evaluations, Quality of Life

Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center

5,467 works263,959 citationsh-index: 230

Jill P. Mesirov University of California San Diego

472 works223,662 citationsh-index: 85

Nikolaus Schultz Memorial Sloan Kettering Cancer Center

1,817 works207,515 citationsh-index: 162

Edward L. Giovannucci Harvard University

2,686 works189,208 citationsh-index: 200

Adrian L. Harris Cancer Research UK

2,092 works156,186 citationsh-index: 187

Indirect Treatment Comparison between Ribociclib Combined with Non-Steroidal Aromatase Inhibitors and Ovarian Function Suppression vs. Tamoxifen in Premenopausal Women with Early Breast Cancer

D. Lüftner,Maggie Banys-Paluchowski,et al.

20260 citations

Abstract PS3-08-14: Typer—A randomized controlled trial evaluating the effect of typology-based coaching on therapy management for patients with hr+/her2- early breast cancer under adjuvant ribociclib treatment

M. Welslau,Christine Zeder-Goess,et al.

20260 citations

Abstract PS1-12-05: Liquid Biopsy-Based Molecular Profiling Using Guardant360 CDx at Progression on CDK4/6i+ET: Findings from the AGO-B CAPTOR Study

Volkmar Mueller,Henry J. Huebner,et al.

20260 citations

Abstract PS5-04-27: Quality of life in patients with advanced breast cancer (aBC) treated with ribociclib (RIB) in the real-world RIBANNA trial

P. A. Fasching,C. Brucker,et al.

20260 citations

Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial

Klaus G Parhofer,Ulrich Julius,et al.

20261 citations